PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

NCT00508586 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: PTC299

Sponsor

PTC Therapeutics

Collaborators

[object Object]